Subscribe to our Newsletters !!

    COVID-19

    Oxford University says COVID-19 patients experience symptoms months subsequent to contracting virus

    Britain’s Oxford University said on Monday first findings from a study on the long term effect of COVID-19 has discovered a lot of patients discharged from hospitals still experience symptoms of breathlessness, fatigue, depression and anxiety two to three months after contracting the virus. The scientists detected abnormalities in many organs and believe persistent inflammation

    SARS-CoV-2 Antibodies and Antigens for Diagnostic Kit Development

    AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of SARS-CoV-2 antibodies and antigens to aid development of new immunoassay diagnostic kits. While RT-PCR diagnostic kits has provided fast and sensitive COVID-19 case confirmation, the technique suffers from some inherent drawbacks that limit

    Atik Cameras Develops New Products for Use with qPCR Instruments for Accurate, Reliable COVID-19 Testing

    NORWICH, UK – (October 22, 2020) – Life Science Newswire – In response to global demand for dependable technologies designed to optimize COVID-19 testing, Atik Cameras, specialist designer and manufacturer of advanced scientific imaging solutions, has developed the new VS255 and VS825 cameras for use specifically with quantitative Polymerase Chain Reaction (qPCR) instruments — the

    GSK, Sanofi to make 200 million doses accessible for COVID-19 antibody union

    French drugmaker Sanofi SA and Britain’s GlaxoSmithKline plan to create 200 million doses of the COVID-19 vaccine candidate accessible to the vaccine allocation program co-led by GAVI and the World Health Organization. The companies said on October 28 they have signed a statement of intent with vaccine alliance GAVI, which is coordinating the global plan

    WHO-drove COVID-19 medication plot copies down on antibodies, steroids and disregards remdesivir

    A World Health Organization-led scheme to provide COVID-19 drugs to poor countries is gambling on experimental monoclonal antibody treatments and steroids but is shunning Gilead’s remdesivir blockbuster therapy, an internal document shows. The WHO draft document, seen by Reuters and dated October 30, states the priorities are to secure monoclonal antibodies in a tight market

    Singapore working on making sure about arrangement of COVID-19 vaccines

    Singapore will work towards procuring a”portfolio” of all COVID-19 vaccines to appeal to various parts of the populace instead of relying upon a single vaccine,” Health Minister Gan Kim Yong said on November 10. Speaking during a digital media conference by the multi-ministry job force on COVID-19, Gan said that the application of a vaccine

    COVID-19 IgG Quantitative Antibody Blood Test of Abbott recieved CE mark

    Abbott has received CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin G) lab-based serology test. IgG antibody testing that gives a quantitative result (measuring the amount of antibodies) provides important insights to people as they recover from COVID-19 and help evaluate a person’s immune response to a vaccine. Countries around the world are preparing

    BD Announces Assay for Identification of COVID-19 Patients

    EYSINS, Switzerland, February 03, 2021/BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE mark of BD Multitest™ 6-Color TBNK Reagent with BD Trucount™ Tubes with expanded clinical application to help clinicians identify COVID-19 patients at increased relative risk of intubation with mechanical ventilation (IMV) and mortality at